How much is the Antiemetic Drug Market market?

The antiemetic drug market market size is estimated to grow at $$ 1723.7 mn in 2023. Read More

What is the growth rate of the Antiemetic Drug Market market?

The growth rate of the antiemetic drug market year-over-year is 6.48%. Read More

Which region held the largest market share in the Antiemetic Drug Market market?

North America is the region to held the largest market share with 41% growth. Read More

Who are the key players in the Antiemetic Drug Market market?

Algen Healthcare Ltd., Boehringer Ingelheim International GmbH, Bristol Laboratories Ltd., Cadila Pharmaceuticals Ltd., Cipla Inc., Eagle Pharmaceuticals Inc., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, .... Read More

Which Segment has the largest market share in the Antiemetic Drug Market market?

Drug Class is the segment that has the largest market share in the market. Read More

Antiemetic Drug Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, China, Germany, UK, Japan - Size and Forecast 2024-2028

Published: Aug 2024
Pages: 184
SKU: IRTNTR75902

Enjoy complimentary customisation on priority with our Enterprise License!

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market

2.2 Market characteristics
- Market characteristics analysis

2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition

3.2 Market segment analysis
- Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Antiemetic Drug Market 2018 - 2022
- Historic Market Size - Data Table on Global Antiemetic Drug Market 2018 - 2022 ($ million)

4.2 Drug Class segment analysis 2018 - 2022
- Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)

4.3 Application segment analysis 2018 - 2022
- Historic Market Size - Application Segment 2018 - 2022 ($ million)

4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)

4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028

5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Drug Class

6.1 Market segments
- Chart on Drug Class - Market share 2023-2028 (%)
- Data Table on Drug Class - Market share 2023-2028 (%)

6.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class

5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Market size and forecast 2023-2028
- Chart on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Market size and forecast 2023-2028 ($ million)
- Data Table on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Market size and forecast 2023-2028 ($ million)
- Chart on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Year-over-year growth 2023-2028 (%)
- Data Table on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Year-over-year growth 2023-2028 (%)

6.4 Dopamine antagonist - Market size and forecast 2023-2028
- Chart on Dopamine antagonist - Market size and forecast 2023-2028 ($ million)
- Data Table on Dopamine antagonist - Market size and forecast 2023-2028 ($ million)
- Chart on Dopamine antagonist - Year-over-year growth 2023-2028 (%)
- Data Table on Dopamine antagonist - Year-over-year growth 2023-2028 (%)

6.5 Neurokinin-1 (NK 1) receptor antagonist - Market size and forecast 2023-2028
- Chart on Neurokinin-1 (NK 1) receptor antagonist - Market size and forecast 2023-2028 ($ million)
- Data Table on Neurokinin-1 (NK 1) receptor antagonist - Market size and forecast 2023-2028 ($ million)
- Chart on Neurokinin-1 (NK 1) receptor antagonist - Year-over-year growth 2023-2028 (%)
- Data Table on Neurokinin-1 (NK 1) receptor antagonist - Year-over-year growth 2023-2028 (%)

6.6 Cannabinoid receptor antagonist - Market size and forecast 2023-2028
- Chart on Cannabinoid receptor antagonist - Market size and forecast 2023-2028 ($ million)
- Data Table on Cannabinoid receptor antagonist - Market size and forecast 2023-2028 ($ million)
- Chart on Cannabinoid receptor antagonist - Year-over-year growth 2023-2028 (%)
- Data Table on Cannabinoid receptor antagonist - Year-over-year growth 2023-2028 (%)

6.7 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)

6.8 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)

7 Market Segmentation by Application

7.1 Market segments
- Chart on Application - Market share 2023-2028 (%)
- Data Table on Application - Market share 2023-2028 (%)

7.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application

7.3 Chemotherapy - Market size and forecast 2023-2028
- Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
- Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
- Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
- Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)

7.4 Surgery - Market size and forecast 2023-2028
- Chart on Surgery - Market size and forecast 2023-2028 ($ million)
- Data Table on Surgery - Market size and forecast 2023-2028 ($ million)
- Chart on Surgery - Year-over-year growth 2023-2028 (%)
- Data Table on Surgery - Year-over-year growth 2023-2028 (%)

7.5 Gastroenteritis - Market size and forecast 2023-2028
- Chart on Gastroenteritis - Market size and forecast 2023-2028 ($ million)
- Data Table on Gastroenteritis - Market size and forecast 2023-2028 ($ million)
- Chart on Gastroenteritis - Year-over-year growth 2023-2028 (%)
- Data Table on Gastroenteritis - Year-over-year growth 2023-2028 (%)

7.6 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)

7.7 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)

9.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.10 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)

9.11 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028

10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview

11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation

11.3 Landscape disruption
- Overview on factors of disruption

11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered

12.2 Market positioning of companies
- Matrix on companies position and classification

12.3 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings

12.4 Cadila Pharmaceuticals Ltd.
- Cadila Pharmaceuticals Ltd. - Overview
- Cadila Pharmaceuticals Ltd. - Product / Service
- Cadila Pharmaceuticals Ltd. - Key offerings

12.5 Cipla Inc.
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus

12.6 Fresenius SE and Co. KGaA
- Fresenius SE and Co. KGaA - Overview
- Fresenius SE and Co. KGaA - Business segments
- Fresenius SE and Co. KGaA - Key news
- Fresenius SE and Co. KGaA - Key offerings
- Fresenius SE and Co. KGaA - Segment focus

12.7 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus

12.8 Helsinn Healthcare SA
- Helsinn Healthcare SA - Overview
- Helsinn Healthcare SA - Product / Service
- Helsinn Healthcare SA - Key offerings

12.9 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus

12.10 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus

12.11 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus

12.12 Otsuka Holdings Co. Ltd.
- Otsuka Holdings Co. Ltd. - Overview
- Otsuka Holdings Co. Ltd. - Business segments
- Otsuka Holdings Co. Ltd. - Key news
- Otsuka Holdings Co. Ltd. - Key offerings
- Otsuka Holdings Co. Ltd. - Segment focus

12.13 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings

12.14 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus

12.15 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings

12.16 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus

12.17 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus

13 Appendix